Germany
Japan
United Kingdom
China
AAV2 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
AAV Control Particles
View as table Download
AAV9 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 2 x 50 ul
AAV2 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 2 x 50 ul
AAV8 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 2 x 50 ul
AAV5 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 2 x 50 ul
AAV-PHP.eB with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
AAVDJ with CMV promoter-driven expression of GFP, >10^13 GC/mL, 2 x 50 ul
AAV8 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
AAV9 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
AAVDJ with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
AAVDJ with CMV promoter-driven expression of P53-GFP, >10^13 GC/mL, 2 x 50 ul
AAVDJ with CMV promoter-driven expression of P53-GFP, >10^13 GC/mL, 50 ul
AAV3 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 2 x 50 ul
AAV3 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
AAV6 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 2 x 50 ul
